On 12 February 2016
Relish Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 February 2016, to consider, adopt and approve Un-audited Financial Results for the quarter ended on 31 December 2015.Powered by Capital Market - Live News
